Form 4 Tracker
Jeffrey M Leiden

Director · 1 filing · Latest: May 7, 2026

Odyssey Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ODTX
Jeffrey M LeidenDirectorMay 11, 2026
Option Exercise
2,96331,661
ODTX
Jeffrey M LeidenDirectorMay 8, 2026
Purchase
$20.005,000$100.0K270,198